Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000–2010

WA Kaplan, LS Ritz, M Vitello, VJ Wirtz - Health policy, 2012 - Elsevier
OBJECTIVE: Review the literature on the impact of policies designed to enhance uptake of
generic medicines in low and middle income countries (LMICs). METHODS: We searched …

Consumers' views on generic medicines: a review of the literature

MAA Hassali, AA Shafie, S Jamshed… - … Journal of Pharmacy …, 2009 - academic.oup.com
Objectives To review the literature on consumers' knowledge, attitudes and opinions of the
use of generic medicines. Method A narrative review of studies conducted from 1970 to …

Patients' beliefs towards generic medicines in the United Arab Emirates

I Guella, N Hassan, M Shahwan… - Research Journal of …, 2021 - search.proquest.com
Objectives: Patients play an important role in activating the generic medicine policy as their
acceptance of it reported as an essential factor. Therefore, this study aimed to explore the …

Patients' beliefs toward generic medication in Yemen

AAS Jaber, YM Al-Worafi… - Journal of Generic …, 2022 - journals.sagepub.com
Purpose This study aims to explore patients' knowledge and beliefs toward generic
medicines and identify the factors affecting their beliefs toward them in Yemen. Patients and …

Knowledge, beliefs and factors affecting the use of generic medicines among patients in Ibb, Yemen: A mixed-method study

YM Al-Worafi, WM Alseragi, KM Alakhali… - Journal of Pharmacy …, 2020 - jppcm.org
Objectives: This study was aimed to explore the knowledge and beliefs of patients in Ibb,
Yemen, regarding generic medicines and identify factors affecting their use of these …

Comparing generic drug markets in Europe and the United States: prices, volumes, and spending

OJ Wouters, PG Kanavos, M McKee - The Milbank Quarterly, 2017 - Wiley Online Library
Policy Points: Our study indicates that there are opportunities for cost savings in generic
drug markets in Europe and the United States. Regulators should make it easier for generic …

[HTML][HTML] Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?

A Cameron, AK Mantel-Teeuwisse, HGM Leufkens… - Value in health, 2012 - Elsevier
Objectives In low-and middle-income countries, patients and reimbursement agencies that
purchase medicines in the private sector pay more for originator brands when generic …

Sustaining generic medicines markets in Europe

S Simoens, S De Coster - Journal of Generic Medicines, 2006 - journals.sagepub.com
The size of generic medicines retail markets varies widely among European countries,
owing to differences in the policy environment surrounding generic medicines. This study …

An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland

ZUD Babar, J Stewart, S Reddy, W Alzaher… - Pharmacy world & …, 2010 - Springer
Objectives The aim of this project was to evaluate the perceptions, knowledge and attitudes
regarding generic medicines. Methods A cross-sectional study, with self administered …

Competition in off-patent drug markets: Issues, regulation and evidence

P Kanavos, J Costa-Font, E Seeley - Economic policy, 2008 - academic.oup.com
In recent years health insurers have placed a great deal of emphasis on the ability of generic
medicines to deliver significant savings to overstretched health care budgets due to their …